Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published August 15, 2022 | Version v1
Dataset Open

A promising target for non-hormonal contraception – The a/b Hydrolase Domain 2

  • 1. Structural Genomics Consortium, Karolinska Institute

Description

Summary of results in 2022 for a/b Hydrolase Domain 2 (ABHD2) in the scope of the Structural Genomics Consortium's Women’s and Children’s Health Initiative funded by the Bill & Melinda Gates Foundation for characterizing potential targets for new non-hormonal contraceptives.

Files

SGC_NHC_OA_ABHD2_AnnualReport_2022_v3.pdf

Files (1.3 MB)

Name Size Download all
md5:20626c2df0f54272c9cc40ac238d02ab
1.3 MB Preview Download